ÉTUDE PRODIGE 74-GERCOR-NIPISAFE - En cours de recrutement

Title

Efficacy and Safety of Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI Metastatic Colorectal Cancer

Coordonateur

COHEN R

Co-Coordonateur

Promoteur

GERCOR

Localisation

Cancer Colorectal Métastatique

Phase

IIR

NOMBRE DE PATIENTS ATTENDU

96

Statut

En cours de recrutement

CONTACT

c-dumasbonnetain@unicancer.fr